• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
  

PubMed=2344964; DOI=10.1016/0090-8258(90)90332-F
Seija E. Grenman, Maria J. Worsham, Daniel L. Van Dyke, Barry England, Kenneth Donald McClatchey, V. Ramesh Babu, James A. Roberts, Johanna U. Maenpaa, Thomas E. Carey;
Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.
Gynecol. Oncol. 37:188-199(1990)

PubMed=1541432; DOI=10.1016/0090-8258(92)90045-K
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Tuula Salmi, Reidar Grenman;
Radiation sensitivity of endometrial carcinoma in vitro.
Gynecol. Oncol. 44:217-222(1992)

PubMed=7798295; DOI=10.1007/BF01194268
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Kalle Alanen, Taina Lakkala, Reidar Grenman;
Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.
J. Cancer Res. Clin. Oncol. 120:712-716(1994)

PubMed=8123477; DOI=10.1038/bjc.1994.87; PMCID=PMC1968845
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Reidar Grenman;
Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
Br. J. Cancer 69:482-486(1994)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Virpi Rantanen, Seija E. Grenman, Kaisa Kurvinen, Sakari H. Hietanen, Misa Raitanen, Stina M. Syrjanen;
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)